Global Vaccine Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or 'wild' pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
United States market for Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Vaccine players cover AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Vaccine Industry Forecast” looks at past sales and reviews total world Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine sales for 2025 through 2031. With Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or 'wild' pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
United States market for Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Vaccine players cover AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Vaccine Industry Forecast” looks at past sales and reviews total world Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine sales for 2025 through 2031. With Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Varicella Vaccine
- Influenza Vaccine
- Polio Vaccine
- Hepatitis A Vaccine
- Rabies Vaccine
- BCG Vaccine
- Hepatitis B
- Pertussis, Diphtheria, Tetanus
- Pneumococcal
- Others
- For Adult
- For Child
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- BioNTech
- Boehringer-Ingelheim
- CCBIO
- CSL
- CureVac
- Elanco
- GSK
- Hulan Bio
- Indian Immunologicals
- Merck
- Minhai Biotechnology
- Mitsubishi Tanabe Pharma
- Moderna Therapeutics
- Mylan
- Plumbline Life Sciences
- Sanofi
- Translate Bio
- Walvax Biotechnology
- Wuhan Institute of Biological Products
- Zoties
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Market Size (2020-2031)
2.1.2 Vaccine Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Vaccine by Country/Region (2020, 2024 & 2031)
2.2 Vaccine Segment by Type
2.2.1 Varicella Vaccine
2.2.2 Influenza Vaccine
2.2.3 Polio Vaccine
2.2.4 Hepatitis A Vaccine
2.2.5 Rabies Vaccine
2.2.6 BCG Vaccine
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.3 Vaccine Market Size by Type
2.3.1 Vaccine Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Vaccine Market Size Market Share by Type (2020-2025)
2.4 Vaccine Segment by Application
2.4.1 For Adult
2.4.2 For Child
2.5 Vaccine Market Size by Application
2.5.1 Vaccine Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Vaccine Market Size Market Share by Application (2020-2025)
3 VACCINE MARKET SIZE BY PLAYER
3.1 Vaccine Market Size Market Share by Player
3.1.1 Global Vaccine Revenue by Player (2020-2025)
3.1.2 Global Vaccine Revenue Market Share by Player (2020-2025)
3.2 Global Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VACCINE BY REGION
4.1 Vaccine Market Size by Region (2020-2025)
4.2 Global Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine Market Size Growth (2020-2025)
4.4 APAC Vaccine Market Size Growth (2020-2025)
4.5 Europe Vaccine Market Size Growth (2020-2025)
4.6 Middle East & Africa Vaccine Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Vaccine Market Size by Country (2020-2025)
5.2 Americas Vaccine Market Size by Type (2020-2025)
5.3 Americas Vaccine Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Market Size by Region (2020-2025)
6.2 APAC Vaccine Market Size by Type (2020-2025)
6.3 APAC Vaccine Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vaccine Market Size by Country (2020-2025)
7.2 Europe Vaccine Market Size by Type (2020-2025)
7.3 Europe Vaccine Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine by Region (2020-2025)
8.2 Middle East & Africa Vaccine Market Size by Type (2020-2025)
8.3 Middle East & Africa Vaccine Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VACCINE MARKET FORECAST
10.1 Global Vaccine Forecast by Region (2026-2031)
10.1.1 Global Vaccine Forecast by Region (2026-2031)
10.1.2 Americas Vaccine Forecast
10.1.3 APAC Vaccine Forecast
10.1.4 Europe Vaccine Forecast
10.1.5 Middle East & Africa Vaccine Forecast
10.2 Americas Vaccine Forecast by Country (2026-2031)
10.2.1 United States Market Vaccine Forecast
10.2.2 Canada Market Vaccine Forecast
10.2.3 Mexico Market Vaccine Forecast
10.2.4 Brazil Market Vaccine Forecast
10.3 APAC Vaccine Forecast by Region (2026-2031)
10.3.1 China Vaccine Market Forecast
10.3.2 Japan Market Vaccine Forecast
10.3.3 Korea Market Vaccine Forecast
10.3.4 Southeast Asia Market Vaccine Forecast
10.3.5 India Market Vaccine Forecast
10.3.6 Australia Market Vaccine Forecast
10.4 Europe Vaccine Forecast by Country (2026-2031)
10.4.1 Germany Market Vaccine Forecast
10.4.2 France Market Vaccine Forecast
10.4.3 UK Market Vaccine Forecast
10.4.4 Italy Market Vaccine Forecast
10.4.5 Russia Market Vaccine Forecast
10.5 Middle East & Africa Vaccine Forecast by Region (2026-2031)
10.5.1 Egypt Market Vaccine Forecast
10.5.2 South Africa Market Vaccine Forecast
10.5.3 Israel Market Vaccine Forecast
10.5.4 Turkey Market Vaccine Forecast
10.6 Global Vaccine Forecast by Type (2026-2031)
10.7 Global Vaccine Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Vaccine Forecast
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Vaccine Product Offered
11.1.3 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech Vaccine Product Offered
11.2.3 BioNTech Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Information
11.3.2 Boehringer-Ingelheim Vaccine Product Offered
11.3.3 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Boehringer-Ingelheim Main Business Overview
11.3.5 Boehringer-Ingelheim Latest Developments
11.4 CCBIO
11.4.1 CCBIO Company Information
11.4.2 CCBIO Vaccine Product Offered
11.4.3 CCBIO Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 CCBIO Main Business Overview
11.4.5 CCBIO Latest Developments
11.5 CSL
11.5.1 CSL Company Information
11.5.2 CSL Vaccine Product Offered
11.5.3 CSL Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 CSL Main Business Overview
11.5.5 CSL Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac Vaccine Product Offered
11.6.3 CureVac Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Elanco
11.7.1 Elanco Company Information
11.7.2 Elanco Vaccine Product Offered
11.7.3 Elanco Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Elanco Main Business Overview
11.7.5 Elanco Latest Developments
11.8 GSK
11.8.1 GSK Company Information
11.8.2 GSK Vaccine Product Offered
11.8.3 GSK Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 GSK Main Business Overview
11.8.5 GSK Latest Developments
11.9 Hulan Bio
11.9.1 Hulan Bio Company Information
11.9.2 Hulan Bio Vaccine Product Offered
11.9.3 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Hulan Bio Main Business Overview
11.9.5 Hulan Bio Latest Developments
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Information
11.10.2 Indian Immunologicals Vaccine Product Offered
11.10.3 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Indian Immunologicals Main Business Overview
11.10.5 Indian Immunologicals Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine Product Offered
11.11.3 Merck Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Information
11.12.2 Minhai Biotechnology Vaccine Product Offered
11.12.3 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Minhai Biotechnology Main Business Overview
11.12.5 Minhai Biotechnology Latest Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Information
11.13.2 Mitsubishi Tanabe Pharma Vaccine Product Offered
11.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Mitsubishi Tanabe Pharma Main Business Overview
11.13.5 Mitsubishi Tanabe Pharma Latest Developments
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Information
11.14.2 Moderna Therapeutics Vaccine Product Offered
11.14.3 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Moderna Therapeutics Main Business Overview
11.14.5 Moderna Therapeutics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Vaccine Product Offered
11.15.3 Mylan Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Information
11.16.2 Plumbline Life Sciences Vaccine Product Offered
11.16.3 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Plumbline Life Sciences Main Business Overview
11.16.5 Plumbline Life Sciences Latest Developments
11.17 Sanofi
11.17.1 Sanofi Company Information
11.17.2 Sanofi Vaccine Product Offered
11.17.3 Sanofi Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Sanofi Main Business Overview
11.17.5 Sanofi Latest Developments
11.18 Translate Bio
11.18.1 Translate Bio Company Information
11.18.2 Translate Bio Vaccine Product Offered
11.18.3 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Translate Bio Main Business Overview
11.18.5 Translate Bio Latest Developments
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Information
11.19.2 Walvax Biotechnology Vaccine Product Offered
11.19.3 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Walvax Biotechnology Main Business Overview
11.19.5 Walvax Biotechnology Latest Developments
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Information
11.20.2 Wuhan Institute of Biological Products Vaccine Product Offered
11.20.3 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Wuhan Institute of Biological Products Main Business Overview
11.20.5 Wuhan Institute of Biological Products Latest Developments
11.21 Zoties
11.21.1 Zoties Company Information
11.21.2 Zoties Vaccine Product Offered
11.21.3 Zoties Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Zoties Main Business Overview
11.21.5 Zoties Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Market Size (2020-2031)
2.1.2 Vaccine Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Vaccine by Country/Region (2020, 2024 & 2031)
2.2 Vaccine Segment by Type
2.2.1 Varicella Vaccine
2.2.2 Influenza Vaccine
2.2.3 Polio Vaccine
2.2.4 Hepatitis A Vaccine
2.2.5 Rabies Vaccine
2.2.6 BCG Vaccine
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.3 Vaccine Market Size by Type
2.3.1 Vaccine Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Vaccine Market Size Market Share by Type (2020-2025)
2.4 Vaccine Segment by Application
2.4.1 For Adult
2.4.2 For Child
2.5 Vaccine Market Size by Application
2.5.1 Vaccine Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Vaccine Market Size Market Share by Application (2020-2025)
3 VACCINE MARKET SIZE BY PLAYER
3.1 Vaccine Market Size Market Share by Player
3.1.1 Global Vaccine Revenue by Player (2020-2025)
3.1.2 Global Vaccine Revenue Market Share by Player (2020-2025)
3.2 Global Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VACCINE BY REGION
4.1 Vaccine Market Size by Region (2020-2025)
4.2 Global Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine Market Size Growth (2020-2025)
4.4 APAC Vaccine Market Size Growth (2020-2025)
4.5 Europe Vaccine Market Size Growth (2020-2025)
4.6 Middle East & Africa Vaccine Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Vaccine Market Size by Country (2020-2025)
5.2 Americas Vaccine Market Size by Type (2020-2025)
5.3 Americas Vaccine Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Market Size by Region (2020-2025)
6.2 APAC Vaccine Market Size by Type (2020-2025)
6.3 APAC Vaccine Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vaccine Market Size by Country (2020-2025)
7.2 Europe Vaccine Market Size by Type (2020-2025)
7.3 Europe Vaccine Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine by Region (2020-2025)
8.2 Middle East & Africa Vaccine Market Size by Type (2020-2025)
8.3 Middle East & Africa Vaccine Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VACCINE MARKET FORECAST
10.1 Global Vaccine Forecast by Region (2026-2031)
10.1.1 Global Vaccine Forecast by Region (2026-2031)
10.1.2 Americas Vaccine Forecast
10.1.3 APAC Vaccine Forecast
10.1.4 Europe Vaccine Forecast
10.1.5 Middle East & Africa Vaccine Forecast
10.2 Americas Vaccine Forecast by Country (2026-2031)
10.2.1 United States Market Vaccine Forecast
10.2.2 Canada Market Vaccine Forecast
10.2.3 Mexico Market Vaccine Forecast
10.2.4 Brazil Market Vaccine Forecast
10.3 APAC Vaccine Forecast by Region (2026-2031)
10.3.1 China Vaccine Market Forecast
10.3.2 Japan Market Vaccine Forecast
10.3.3 Korea Market Vaccine Forecast
10.3.4 Southeast Asia Market Vaccine Forecast
10.3.5 India Market Vaccine Forecast
10.3.6 Australia Market Vaccine Forecast
10.4 Europe Vaccine Forecast by Country (2026-2031)
10.4.1 Germany Market Vaccine Forecast
10.4.2 France Market Vaccine Forecast
10.4.3 UK Market Vaccine Forecast
10.4.4 Italy Market Vaccine Forecast
10.4.5 Russia Market Vaccine Forecast
10.5 Middle East & Africa Vaccine Forecast by Region (2026-2031)
10.5.1 Egypt Market Vaccine Forecast
10.5.2 South Africa Market Vaccine Forecast
10.5.3 Israel Market Vaccine Forecast
10.5.4 Turkey Market Vaccine Forecast
10.6 Global Vaccine Forecast by Type (2026-2031)
10.7 Global Vaccine Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Vaccine Forecast
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Vaccine Product Offered
11.1.3 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech Vaccine Product Offered
11.2.3 BioNTech Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Information
11.3.2 Boehringer-Ingelheim Vaccine Product Offered
11.3.3 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Boehringer-Ingelheim Main Business Overview
11.3.5 Boehringer-Ingelheim Latest Developments
11.4 CCBIO
11.4.1 CCBIO Company Information
11.4.2 CCBIO Vaccine Product Offered
11.4.3 CCBIO Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 CCBIO Main Business Overview
11.4.5 CCBIO Latest Developments
11.5 CSL
11.5.1 CSL Company Information
11.5.2 CSL Vaccine Product Offered
11.5.3 CSL Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 CSL Main Business Overview
11.5.5 CSL Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac Vaccine Product Offered
11.6.3 CureVac Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Elanco
11.7.1 Elanco Company Information
11.7.2 Elanco Vaccine Product Offered
11.7.3 Elanco Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Elanco Main Business Overview
11.7.5 Elanco Latest Developments
11.8 GSK
11.8.1 GSK Company Information
11.8.2 GSK Vaccine Product Offered
11.8.3 GSK Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 GSK Main Business Overview
11.8.5 GSK Latest Developments
11.9 Hulan Bio
11.9.1 Hulan Bio Company Information
11.9.2 Hulan Bio Vaccine Product Offered
11.9.3 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Hulan Bio Main Business Overview
11.9.5 Hulan Bio Latest Developments
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Information
11.10.2 Indian Immunologicals Vaccine Product Offered
11.10.3 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Indian Immunologicals Main Business Overview
11.10.5 Indian Immunologicals Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine Product Offered
11.11.3 Merck Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Information
11.12.2 Minhai Biotechnology Vaccine Product Offered
11.12.3 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Minhai Biotechnology Main Business Overview
11.12.5 Minhai Biotechnology Latest Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Information
11.13.2 Mitsubishi Tanabe Pharma Vaccine Product Offered
11.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Mitsubishi Tanabe Pharma Main Business Overview
11.13.5 Mitsubishi Tanabe Pharma Latest Developments
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Information
11.14.2 Moderna Therapeutics Vaccine Product Offered
11.14.3 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Moderna Therapeutics Main Business Overview
11.14.5 Moderna Therapeutics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Vaccine Product Offered
11.15.3 Mylan Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Information
11.16.2 Plumbline Life Sciences Vaccine Product Offered
11.16.3 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Plumbline Life Sciences Main Business Overview
11.16.5 Plumbline Life Sciences Latest Developments
11.17 Sanofi
11.17.1 Sanofi Company Information
11.17.2 Sanofi Vaccine Product Offered
11.17.3 Sanofi Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Sanofi Main Business Overview
11.17.5 Sanofi Latest Developments
11.18 Translate Bio
11.18.1 Translate Bio Company Information
11.18.2 Translate Bio Vaccine Product Offered
11.18.3 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Translate Bio Main Business Overview
11.18.5 Translate Bio Latest Developments
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Information
11.19.2 Walvax Biotechnology Vaccine Product Offered
11.19.3 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Walvax Biotechnology Main Business Overview
11.19.5 Walvax Biotechnology Latest Developments
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Information
11.20.2 Wuhan Institute of Biological Products Vaccine Product Offered
11.20.3 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Wuhan Institute of Biological Products Main Business Overview
11.20.5 Wuhan Institute of Biological Products Latest Developments
11.21 Zoties
11.21.1 Zoties Company Information
11.21.2 Zoties Vaccine Product Offered
11.21.3 Zoties Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Zoties Main Business Overview
11.21.5 Zoties Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccine Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Varicella Vaccine
Table 4. Major Players of Influenza Vaccine
Table 5. Major Players of Polio Vaccine
Table 6. Major Players of Hepatitis A Vaccine
Table 7. Major Players of Rabies Vaccine
Table 8. Major Players of BCG Vaccine
Table 9. Major Players of Hepatitis B
Table 10. Major Players of Pertussis, Diphtheria,Tetanus
Table 11. Major Players of Pneumococcal
Table 12. Vaccine Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Vaccine Market Size byType (2020-2025) & ($ millions)
Table 14. Global Vaccine Market Size Market Share byType (2020-2025)
Table 15. Vaccine Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 16. Global Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 17. Global Vaccine Market Size Market Share by Application (2020-2025)
Table 18. Global Vaccine Revenue by Player (2020-2025) & ($ millions)
Table 19. Global Vaccine Revenue Market Share by Player (2020-2025)
Table 20. Vaccine Key Players Head office and Products Offered
Table 21. Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 25. Global Vaccine Market Size Market Share by Region (2020-2025)
Table 26. Global Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 27. Global Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 28. Americas Vaccine Market Size by Country (2020-2025) & ($ millions)
Table 29. Americas Vaccine Market Size Market Share by Country (2020-2025)
Table 30. Americas Vaccine Market Size byType (2020-2025) & ($ millions)
Table 31. Americas Vaccine Market Size Market Share byType (2020-2025)
Table 32. Americas Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 33. Americas Vaccine Market Size Market Share by Application (2020-2025)
Table 34. APAC Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 35. APAC Vaccine Market Size Market Share by Region (2020-2025)
Table 36. APAC Vaccine Market Size byType (2020-2025) & ($ millions)
Table 37. APAC Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 38. Europe Vaccine Market Size by Country (2020-2025) & ($ millions)
Table 39. Europe Vaccine Market Size Market Share by Country (2020-2025)
Table 40. Europe Vaccine Market Size byType (2020-2025) & ($ millions)
Table 41. Europe Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 42. Middle East & Africa Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 43. Middle East & Africa Vaccine Market Size byType (2020-2025) & ($ millions)
Table 44. Middle East & Africa Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 45. Key Market Drivers & Growth Opportunities of Vaccine
Table 46. Key Market Challenges & Risks of Vaccine
Table 47. Key IndustryTrends of Vaccine
Table 48. Global Vaccine Market SizeForecast by Region (2026-2031) & ($ millions)
Table 49. Global Vaccine Market Size Market ShareForecast by Region (2026-2031)
Table 50. Global Vaccine Market SizeForecast byType (2026-2031) & ($ millions)
Table 51. Global Vaccine Market SizeForecast by Application (2026-2031) & ($ millions)
Table 52. AstraZeneca Details, CompanyType, Vaccine Area Served and Its Competitors
Table 53. AstraZeneca Vaccine Product Offered
Table 54. AstraZeneca Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. AstraZeneca Main Business
Table 56. AstraZeneca Latest Developments
Table 57. BioNTech Details, CompanyType, Vaccine Area Served and Its Competitors
Table 58. BioNTech Vaccine Product Offered
Table 59. BioNTech Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. BioNTech Main Business
Table 61. BioNTech Latest Developments
Table 62. Boehringer-Ingelheim Details, CompanyType, Vaccine Area Served and Its Competitors
Table 63. Boehringer-Ingelheim Vaccine Product Offered
Table 64. Boehringer-Ingelheim Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Boehringer-Ingelheim Main Business
Table 66. Boehringer-Ingelheim Latest Developments
Table 67. CCBIO Details, CompanyType, Vaccine Area Served and Its Competitors
Table 68. CCBIO Vaccine Product Offered
Table 69. CCBIO Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. CCBIO Main Business
Table 71. CCBIO Latest Developments
Table 72. CSL Details, CompanyType, Vaccine Area Served and Its Competitors
Table 73. CSL Vaccine Product Offered
Table 74. CSL Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. CSL Main Business
Table 76. CSL Latest Developments
Table 77. CureVac Details, CompanyType, Vaccine Area Served and Its Competitors
Table 78. CureVac Vaccine Product Offered
Table 79. CureVac Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. CureVac Main Business
Table 81. CureVac Latest Developments
Table 82. Elanco Details, CompanyType, Vaccine Area Served and Its Competitors
Table 83. Elanco Vaccine Product Offered
Table 84. Elanco Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Elanco Main Business
Table 86. Elanco Latest Developments
Table 87. GSK Details, CompanyType, Vaccine Area Served and Its Competitors
Table 88. GSK Vaccine Product Offered
Table 89. GSK Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Hulan Bio Details, CompanyType, Vaccine Area Served and Its Competitors
Table 93. Hulan Bio Vaccine Product Offered
Table 94. Hulan Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Hulan Bio Main Business
Table 96. Hulan Bio Latest Developments
Table 97. Indian Immunologicals Details, CompanyType, Vaccine Area Served and Its Competitors
Table 98. Indian Immunologicals Vaccine Product Offered
Table 99. Indian Immunologicals Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Indian Immunologicals Main Business
Table 101. Indian Immunologicals Latest Developments
Table 102. Merck Details, CompanyType, Vaccine Area Served and Its Competitors
Table 103. Merck Vaccine Product Offered
Table 104. Merck Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Minhai Biotechnology Details, CompanyType, Vaccine Area Served and Its Competitors
Table 108. Minhai Biotechnology Vaccine Product Offered
Table 109. Minhai Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Minhai Biotechnology Main Business
Table 111. Minhai Biotechnology Latest Developments
Table 112. MitsubishiTanabe Pharma Details, CompanyType, Vaccine Area Served and Its Competitors
Table 113. MitsubishiTanabe Pharma Vaccine Product Offered
Table 114. MitsubishiTanabe Pharma Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. MitsubishiTanabe Pharma Main Business
Table 116. MitsubishiTanabe Pharma Latest Developments
Table 117. ModernaTherapeutics Details, CompanyType, Vaccine Area Served and Its Competitors
Table 118. ModernaTherapeutics Vaccine Product Offered
Table 119. ModernaTherapeutics Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. ModernaTherapeutics Main Business
Table 121. ModernaTherapeutics Latest Developments
Table 122. Mylan Details, CompanyType, Vaccine Area Served and Its Competitors
Table 123. Mylan Vaccine Product Offered
Table 124. Mylan Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. Mylan Main Business
Table 126. Mylan Latest Developments
Table 127. Plumbline Life Sciences Details, CompanyType, Vaccine Area Served and Its Competitors
Table 128. Plumbline Life Sciences Vaccine Product Offered
Table 129. Plumbline Life Sciences Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 130. Plumbline Life Sciences Main Business
Table 131. Plumbline Life Sciences Latest Developments
Table 132. Sanofi Details, CompanyType, Vaccine Area Served and Its Competitors
Table 133. Sanofi Vaccine Product Offered
Table 134. Sanofi Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 135. Sanofi Main Business
Table 136. Sanofi Latest Developments
Table 137.Translate Bio Details, CompanyType, Vaccine Area Served and Its Competitors
Table 138.Translate Bio Vaccine Product Offered
Table 139.Translate Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 140.Translate Bio Main Business
Table 141.Translate Bio Latest Developments
Table 142. Walvax Biotechnology Details, CompanyType, Vaccine Area Served and Its Competitors
Table 143. Walvax Biotechnology Vaccine Product Offered
Table 144. Walvax Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 145. Walvax Biotechnology Main Business
Table 146. Walvax Biotechnology Latest Developments
Table 147. Wuhan Institute of Biological Products Details, CompanyType, Vaccine Area Served and Its Competitors
Table 148. Wuhan Institute of Biological Products Vaccine Product Offered
Table 149. Wuhan Institute of Biological Products Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 150. Wuhan Institute of Biological Products Main Business
Table 151. Wuhan Institute of Biological Products Latest Developments
Table 152. Zoties Details, CompanyType, Vaccine Area Served and Its Competitors
Table 153. Zoties Vaccine Product Offered
Table 154. Zoties Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 155. Zoties Main Business
Table 156. Zoties Latest Developments
Table 1. Vaccine Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Varicella Vaccine
Table 4. Major Players of Influenza Vaccine
Table 5. Major Players of Polio Vaccine
Table 6. Major Players of Hepatitis A Vaccine
Table 7. Major Players of Rabies Vaccine
Table 8. Major Players of BCG Vaccine
Table 9. Major Players of Hepatitis B
Table 10. Major Players of Pertussis, Diphtheria,Tetanus
Table 11. Major Players of Pneumococcal
Table 12. Vaccine Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Vaccine Market Size byType (2020-2025) & ($ millions)
Table 14. Global Vaccine Market Size Market Share byType (2020-2025)
Table 15. Vaccine Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 16. Global Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 17. Global Vaccine Market Size Market Share by Application (2020-2025)
Table 18. Global Vaccine Revenue by Player (2020-2025) & ($ millions)
Table 19. Global Vaccine Revenue Market Share by Player (2020-2025)
Table 20. Vaccine Key Players Head office and Products Offered
Table 21. Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 25. Global Vaccine Market Size Market Share by Region (2020-2025)
Table 26. Global Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 27. Global Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 28. Americas Vaccine Market Size by Country (2020-2025) & ($ millions)
Table 29. Americas Vaccine Market Size Market Share by Country (2020-2025)
Table 30. Americas Vaccine Market Size byType (2020-2025) & ($ millions)
Table 31. Americas Vaccine Market Size Market Share byType (2020-2025)
Table 32. Americas Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 33. Americas Vaccine Market Size Market Share by Application (2020-2025)
Table 34. APAC Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 35. APAC Vaccine Market Size Market Share by Region (2020-2025)
Table 36. APAC Vaccine Market Size byType (2020-2025) & ($ millions)
Table 37. APAC Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 38. Europe Vaccine Market Size by Country (2020-2025) & ($ millions)
Table 39. Europe Vaccine Market Size Market Share by Country (2020-2025)
Table 40. Europe Vaccine Market Size byType (2020-2025) & ($ millions)
Table 41. Europe Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 42. Middle East & Africa Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 43. Middle East & Africa Vaccine Market Size byType (2020-2025) & ($ millions)
Table 44. Middle East & Africa Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 45. Key Market Drivers & Growth Opportunities of Vaccine
Table 46. Key Market Challenges & Risks of Vaccine
Table 47. Key IndustryTrends of Vaccine
Table 48. Global Vaccine Market SizeForecast by Region (2026-2031) & ($ millions)
Table 49. Global Vaccine Market Size Market ShareForecast by Region (2026-2031)
Table 50. Global Vaccine Market SizeForecast byType (2026-2031) & ($ millions)
Table 51. Global Vaccine Market SizeForecast by Application (2026-2031) & ($ millions)
Table 52. AstraZeneca Details, CompanyType, Vaccine Area Served and Its Competitors
Table 53. AstraZeneca Vaccine Product Offered
Table 54. AstraZeneca Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. AstraZeneca Main Business
Table 56. AstraZeneca Latest Developments
Table 57. BioNTech Details, CompanyType, Vaccine Area Served and Its Competitors
Table 58. BioNTech Vaccine Product Offered
Table 59. BioNTech Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. BioNTech Main Business
Table 61. BioNTech Latest Developments
Table 62. Boehringer-Ingelheim Details, CompanyType, Vaccine Area Served and Its Competitors
Table 63. Boehringer-Ingelheim Vaccine Product Offered
Table 64. Boehringer-Ingelheim Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Boehringer-Ingelheim Main Business
Table 66. Boehringer-Ingelheim Latest Developments
Table 67. CCBIO Details, CompanyType, Vaccine Area Served and Its Competitors
Table 68. CCBIO Vaccine Product Offered
Table 69. CCBIO Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. CCBIO Main Business
Table 71. CCBIO Latest Developments
Table 72. CSL Details, CompanyType, Vaccine Area Served and Its Competitors
Table 73. CSL Vaccine Product Offered
Table 74. CSL Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. CSL Main Business
Table 76. CSL Latest Developments
Table 77. CureVac Details, CompanyType, Vaccine Area Served and Its Competitors
Table 78. CureVac Vaccine Product Offered
Table 79. CureVac Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. CureVac Main Business
Table 81. CureVac Latest Developments
Table 82. Elanco Details, CompanyType, Vaccine Area Served and Its Competitors
Table 83. Elanco Vaccine Product Offered
Table 84. Elanco Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Elanco Main Business
Table 86. Elanco Latest Developments
Table 87. GSK Details, CompanyType, Vaccine Area Served and Its Competitors
Table 88. GSK Vaccine Product Offered
Table 89. GSK Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Hulan Bio Details, CompanyType, Vaccine Area Served and Its Competitors
Table 93. Hulan Bio Vaccine Product Offered
Table 94. Hulan Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Hulan Bio Main Business
Table 96. Hulan Bio Latest Developments
Table 97. Indian Immunologicals Details, CompanyType, Vaccine Area Served and Its Competitors
Table 98. Indian Immunologicals Vaccine Product Offered
Table 99. Indian Immunologicals Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Indian Immunologicals Main Business
Table 101. Indian Immunologicals Latest Developments
Table 102. Merck Details, CompanyType, Vaccine Area Served and Its Competitors
Table 103. Merck Vaccine Product Offered
Table 104. Merck Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Minhai Biotechnology Details, CompanyType, Vaccine Area Served and Its Competitors
Table 108. Minhai Biotechnology Vaccine Product Offered
Table 109. Minhai Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Minhai Biotechnology Main Business
Table 111. Minhai Biotechnology Latest Developments
Table 112. MitsubishiTanabe Pharma Details, CompanyType, Vaccine Area Served and Its Competitors
Table 113. MitsubishiTanabe Pharma Vaccine Product Offered
Table 114. MitsubishiTanabe Pharma Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. MitsubishiTanabe Pharma Main Business
Table 116. MitsubishiTanabe Pharma Latest Developments
Table 117. ModernaTherapeutics Details, CompanyType, Vaccine Area Served and Its Competitors
Table 118. ModernaTherapeutics Vaccine Product Offered
Table 119. ModernaTherapeutics Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. ModernaTherapeutics Main Business
Table 121. ModernaTherapeutics Latest Developments
Table 122. Mylan Details, CompanyType, Vaccine Area Served and Its Competitors
Table 123. Mylan Vaccine Product Offered
Table 124. Mylan Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. Mylan Main Business
Table 126. Mylan Latest Developments
Table 127. Plumbline Life Sciences Details, CompanyType, Vaccine Area Served and Its Competitors
Table 128. Plumbline Life Sciences Vaccine Product Offered
Table 129. Plumbline Life Sciences Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 130. Plumbline Life Sciences Main Business
Table 131. Plumbline Life Sciences Latest Developments
Table 132. Sanofi Details, CompanyType, Vaccine Area Served and Its Competitors
Table 133. Sanofi Vaccine Product Offered
Table 134. Sanofi Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 135. Sanofi Main Business
Table 136. Sanofi Latest Developments
Table 137.Translate Bio Details, CompanyType, Vaccine Area Served and Its Competitors
Table 138.Translate Bio Vaccine Product Offered
Table 139.Translate Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 140.Translate Bio Main Business
Table 141.Translate Bio Latest Developments
Table 142. Walvax Biotechnology Details, CompanyType, Vaccine Area Served and Its Competitors
Table 143. Walvax Biotechnology Vaccine Product Offered
Table 144. Walvax Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 145. Walvax Biotechnology Main Business
Table 146. Walvax Biotechnology Latest Developments
Table 147. Wuhan Institute of Biological Products Details, CompanyType, Vaccine Area Served and Its Competitors
Table 148. Wuhan Institute of Biological Products Vaccine Product Offered
Table 149. Wuhan Institute of Biological Products Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 150. Wuhan Institute of Biological Products Main Business
Table 151. Wuhan Institute of Biological Products Latest Developments
Table 152. Zoties Details, CompanyType, Vaccine Area Served and Its Competitors
Table 153. Zoties Vaccine Product Offered
Table 154. Zoties Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 155. Zoties Main Business
Table 156. Zoties Latest Developments
LIST OF FIGURES
Figure 1. Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Vaccine Sales Market Share by Country/Region (2024)
Figure 8. Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Vaccine Market Size Market Share byType in 2024
Figure 10. Vaccine inFor Adult
Figure 11. Global Vaccine Market:For Adult (2020-2025) & ($ millions)
Figure 12. Vaccine inFor Child
Figure 13. Global Vaccine Market:For Child (2020-2025) & ($ millions)
Figure 14. Global Vaccine Market Size Market Share by Application in 2024
Figure 15. Global Vaccine Revenue Market Share by Player in 2024
Figure 16. Global Vaccine Market Size Market Share by Region (2020-2025)
Figure 17. Americas Vaccine Market Size 2020-2025 ($ millions)
Figure 18. APAC Vaccine Market Size 2020-2025 ($ millions)
Figure 19. Europe Vaccine Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Vaccine Market Size 2020-2025 ($ millions)
Figure 21. Americas Vaccine Value Market Share by Country in 2024
Figure 22. United States Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Vaccine Market Size Market Share by Region in 2024
Figure 27. APAC Vaccine Market Size Market Share byType (2020-2025)
Figure 28. APAC Vaccine Market Size Market Share by Application (2020-2025)
Figure 29. China Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 33. India Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Vaccine Market Size Market Share by Country in 2024
Figure 36. Europe Vaccine Market Size Market Share byType (2020-2025)
Figure 37. Europe Vaccine Market Size Market Share by Application (2020-2025)
Figure 38. Germany Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 39.France Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Vaccine Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Vaccine Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Vaccine Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Vaccine Market Size 2026-2031 ($ millions)
Figure 52. APAC Vaccine Market Size 2026-2031 ($ millions)
Figure 53. Europe Vaccine Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Vaccine Market Size 2026-2031 ($ millions)
Figure 55. United States Vaccine Market Size 2026-2031 ($ millions)
Figure 56. Canada Vaccine Market Size 2026-2031 ($ millions)
Figure 57. Mexico Vaccine Market Size 2026-2031 ($ millions)
Figure 58. Brazil Vaccine Market Size 2026-2031 ($ millions)
Figure 59. China Vaccine Market Size 2026-2031 ($ millions)
Figure 60. Japan Vaccine Market Size 2026-2031 ($ millions)
Figure 61. Korea Vaccine Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Vaccine Market Size 2026-2031 ($ millions)
Figure 63. India Vaccine Market Size 2026-2031 ($ millions)
Figure 64. Australia Vaccine Market Size 2026-2031 ($ millions)
Figure 65. Germany Vaccine Market Size 2026-2031 ($ millions)
Figure 66.France Vaccine Market Size 2026-2031 ($ millions)
Figure 67. UK Vaccine Market Size 2026-2031 ($ millions)
Figure 68. Italy Vaccine Market Size 2026-2031 ($ millions)
Figure 69. Russia Vaccine Market Size 2026-2031 ($ millions)
Figure 70. Egypt Vaccine Market Size 2026-2031 ($ millions)
Figure 71. South Africa Vaccine Market Size 2026-2031 ($ millions)
Figure 72. Israel Vaccine Market Size 2026-2031 ($ millions)
Figure 73.Turkey Vaccine Market Size 2026-2031 ($ millions)
Figure 74. Global Vaccine Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Vaccine Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Vaccine Market Size 2026-2031 ($ millions)
Figure 1. Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Vaccine Sales Market Share by Country/Region (2024)
Figure 8. Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Vaccine Market Size Market Share byType in 2024
Figure 10. Vaccine inFor Adult
Figure 11. Global Vaccine Market:For Adult (2020-2025) & ($ millions)
Figure 12. Vaccine inFor Child
Figure 13. Global Vaccine Market:For Child (2020-2025) & ($ millions)
Figure 14. Global Vaccine Market Size Market Share by Application in 2024
Figure 15. Global Vaccine Revenue Market Share by Player in 2024
Figure 16. Global Vaccine Market Size Market Share by Region (2020-2025)
Figure 17. Americas Vaccine Market Size 2020-2025 ($ millions)
Figure 18. APAC Vaccine Market Size 2020-2025 ($ millions)
Figure 19. Europe Vaccine Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Vaccine Market Size 2020-2025 ($ millions)
Figure 21. Americas Vaccine Value Market Share by Country in 2024
Figure 22. United States Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Vaccine Market Size Market Share by Region in 2024
Figure 27. APAC Vaccine Market Size Market Share byType (2020-2025)
Figure 28. APAC Vaccine Market Size Market Share by Application (2020-2025)
Figure 29. China Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 33. India Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Vaccine Market Size Market Share by Country in 2024
Figure 36. Europe Vaccine Market Size Market Share byType (2020-2025)
Figure 37. Europe Vaccine Market Size Market Share by Application (2020-2025)
Figure 38. Germany Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 39.France Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Vaccine Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Vaccine Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Vaccine Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Vaccine Market Size 2026-2031 ($ millions)
Figure 52. APAC Vaccine Market Size 2026-2031 ($ millions)
Figure 53. Europe Vaccine Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Vaccine Market Size 2026-2031 ($ millions)
Figure 55. United States Vaccine Market Size 2026-2031 ($ millions)
Figure 56. Canada Vaccine Market Size 2026-2031 ($ millions)
Figure 57. Mexico Vaccine Market Size 2026-2031 ($ millions)
Figure 58. Brazil Vaccine Market Size 2026-2031 ($ millions)
Figure 59. China Vaccine Market Size 2026-2031 ($ millions)
Figure 60. Japan Vaccine Market Size 2026-2031 ($ millions)
Figure 61. Korea Vaccine Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Vaccine Market Size 2026-2031 ($ millions)
Figure 63. India Vaccine Market Size 2026-2031 ($ millions)
Figure 64. Australia Vaccine Market Size 2026-2031 ($ millions)
Figure 65. Germany Vaccine Market Size 2026-2031 ($ millions)
Figure 66.France Vaccine Market Size 2026-2031 ($ millions)
Figure 67. UK Vaccine Market Size 2026-2031 ($ millions)
Figure 68. Italy Vaccine Market Size 2026-2031 ($ millions)
Figure 69. Russia Vaccine Market Size 2026-2031 ($ millions)
Figure 70. Egypt Vaccine Market Size 2026-2031 ($ millions)
Figure 71. South Africa Vaccine Market Size 2026-2031 ($ millions)
Figure 72. Israel Vaccine Market Size 2026-2031 ($ millions)
Figure 73.Turkey Vaccine Market Size 2026-2031 ($ millions)
Figure 74. Global Vaccine Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Vaccine Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Vaccine Market Size 2026-2031 ($ millions)
More Publications
Global Syringes Powder Filling Machine Market Growth 2023-2029
US$ 3,660.00
February 2023
105 pages
Global Travelers Vaccines Market Growth 2026-2032
US$ 3,660.00
June 2026
116 pages
Global Medical Gas Flowmeter Market Growth 2024-2030
US$ 3,660.00
August 2024
153 pages
Global Single Coated Medical Tape Market Growth 2024-2030
US$ 3,660.00
December 2024
89 pages
Global Medical Disinfection and Sterilization Equipment Market Growth 2025-2031
US$ 3,660.00
January 2025
154 pages
